Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc.: The Supreme Court Clarifies Skinny Label Patent Infringement and Active Inducement
When does a generic drug’s “skinny label” cross the line into skinny label patent infringement? For years the answer splintered the lower courts, and
Keyhani LLC
September 2, 2026